dipyridamole has been researched along with Eclampsia in 6 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Eclampsia: Onset of HYPERREFLEXIA; SEIZURES; or COMA in a previously diagnosed pre-eclamptic patient (PRE-ECLAMPSIA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of male breast carcinoma is discussed with reference to the effect of steroids on the hormonal receptors at the malignant cell." | 1.26 | [Clinical demonstrations: 1. Renal tubular acidosis; 2. Breast neoplasm with bone metastases in a man; 3. Thrombotic thrombocytopenic purpura; 4. Precocious eclampsia in a 22 years old primipara]. ( Weber, J, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dodd, JM | 2 |
| McLeod, A | 2 |
| Windrim, RC | 2 |
| Kingdom, J | 2 |
| Weber, J | 1 |
| Díaz de León Ponce, M | 1 |
| López-Llera, M | 1 |
| Rubio Linares, G | 1 |
| Bonnar, J | 1 |
| Ponticelli, C | 1 |
| Imbasciati, E | 1 |
| Tarantino, A | 1 |
| Graziani, G | 1 |
| Redaelli, B | 1 |
2 reviews available for dipyridamole and Eclampsia
| Article | Year |
|---|---|
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
Topics: Aspirin; Dipyridamole; Eclampsia; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Low | 2013 |
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
Topics: Dipyridamole; Eclampsia; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Low Birth Wei | 2010 |
4 other studies available for dipyridamole and Eclampsia
| Article | Year |
|---|---|
[Clinical demonstrations: 1. Renal tubular acidosis; 2. Breast neoplasm with bone metastases in a man; 3. Thrombotic thrombocytopenic purpura; 4. Precocious eclampsia in a 22 years old primipara].
Topics: Acidosis, Renal Tubular; Acute Kidney Injury; Adrenal Cortex Hormones; Adult; Aged; Bone Neoplasms; | 1977 |
[Acute renal insufficiency with high urine output in preeclampsia and in eclampsia].
Topics: Acute Kidney Injury; Dipyridamole; Disseminated Intravascular Coagulation; Eclampsia; Female; Humans | 1975 |
Blood coagulation and fibrinolysis in human pregnancy.
Topics: Abruptio Placentae; Blood Coagulation; Blood Coagulation Factors; Dipyridamole; Disseminated Intrava | 1973 |
Post-partum renal failure with microangiopathic haemolytic anaemia. Long-term survival after anticoagulant therapy.
Topics: Acute Kidney Injury; Adult; Anemia, Hemolytic; Anticoagulants; Blood Platelet Disorders; Cesarean Se | 1972 |